<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmaceutical Chemistry &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pharmaceutical-chemistry/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 14:23:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Pharmaceutical Chemistry &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Brain-repair discovery could lead to new epilepsy treatments</title>
		<link>https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/</link>
					<comments>https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 13:25:13 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Trauma/Injury]]></category>
		<guid isPermaLink="false">https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/</guid>

					<description><![CDATA[Credit: Dan Addison &#124; UVA Communications University of Virginia School of Medicine researchers have discovered a previously unknown repair process in the brain that they hope could be harnessed and enhanced to treat seizure-related brain injuries. Common seizure-preventing drugs do not work for approximately a third of epilepsy patients, so new and better treatments for [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/brain-repair-discovery-could-lead-to-new-epilepsy-treatments/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174445</post-id>	</item>
		<item>
		<title>A small molecule induces readthrough of cystic fibrosis CFTR nonsense mutations</title>
		<link>https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/</link>
					<comments>https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 15:50:35 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/</guid>

					<description><![CDATA[This research suggests that a path to treat currently untreatable cases of cystic fibrosis is clearly achievable. Credit: UAB BIRMINGHAM, Ala. &#8211; An experimental drug reported in Nature Communications suggests that a &#8220;path is clearly achievable&#8221; to treat currently untreatable cases of cystic fibrosis disease caused by nonsense mutations. This includes about 11 percent of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174035</post-id>	</item>
		<item>
		<title>CHOP researchers establish novel approach for developing new antibiotics</title>
		<link>https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/</link>
					<comments>https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 14:58:39 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/</guid>

					<description><![CDATA[New study proposes structure-guided design to create prodrugs that act as a &#8220;Trojan Horse,&#8221; allowing antibiotics to reach resistant bacteria Credit: CHOP Philadelphia, July 19, 2021&#8211;Researchers at Children&#8217;s Hospital of Philadelphia (CHOP) have developed a novel method for producing new antibiotics to combat resistant bacteria. Through an approach that would target bacteria with an antibiotic [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174007</post-id>	</item>
		<item>
		<title>Scientists identify new gut-liver drug recycling process</title>
		<link>https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/</link>
					<comments>https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jul 2021 17:22:10 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Liver]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Metabolism/Metabolic Diseases]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<category><![CDATA[Pharmaceutical/Combinatorial Chemistry]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/</guid>

					<description><![CDATA[Implications for developing treatments for intestinal diseases Credit: University of Houston A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines &#8211; followed by recycling through the liver &#8211; that could have important implications for developing treatments for intestinal diseases and for taking multiple medications [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173789</post-id>	</item>
		<item>
		<title>Study shows Cannabis terpenes provide pain relief, contribute to &#8216;entourage effect&#8217;</title>
		<link>https://bioengineer.org/study-shows-cannabis-terpenes-provide-pain-relief-contribute-to-entourage-effect/</link>
					<comments>https://bioengineer.org/study-shows-cannabis-terpenes-provide-pain-relief-contribute-to-entourage-effect/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jul 2021 15:01:55 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Alternative Medicine]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pain]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-shows-cannabis-terpenes-provide-pain-relief-contribute-to-entourage-effect/</guid>

					<description><![CDATA[Credit: University of Arizona Health Sciences/Noelle Haro-Gomez When it comes to the medicinal and therapeutic properties of Cannabis sativa, an unsolved mystery is whether there exists an &#8220;entourage effect,&#8221; whereby the pain-relieving effects of the plant as a whole are greater than any of its individual parts. New research from the University of Arizona Health [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-shows-cannabis-terpenes-provide-pain-relief-contribute-to-entourage-effect/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173747</post-id>	</item>
		<item>
		<title>Microcrystal electron diffraction supports a new drug development pipeline</title>
		<link>https://bioengineer.org/microcrystal-electron-diffraction-supports-a-new-drug-development-pipeline/</link>
					<comments>https://bioengineer.org/microcrystal-electron-diffraction-supports-a-new-drug-development-pipeline/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 21:32:21 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Chemistry/Physics/Materials Sciences]]></category>
		<category><![CDATA[Molecular Biology]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<category><![CDATA[Pharmaceutical/Combinatorial Chemistry]]></category>
		<category><![CDATA[Research/Development]]></category>
		<guid isPermaLink="false">https://bioengineer.org/microcrystal-electron-diffraction-supports-a-new-drug-development-pipeline/</guid>

					<description><![CDATA[Credit: Bruhn, J. et al. Front. Mol. Biosci., 2021 8, 354. CAMBRIDGE July 13, 2021 &#8211; To date, solving structures of potential therapeutics using X-ray diffraction (XRD) has been an assumed, pivotal step in the drug development process. But a recent paper by a team of researchers led by NanoImaging Services shows how microcrystal electron [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/microcrystal-electron-diffraction-supports-a-new-drug-development-pipeline/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173689</post-id>	</item>
		<item>
		<title>Reduced vs. standard CT dose for lung nodules in children, young adults with cancer</title>
		<link>https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/</link>
					<comments>https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jul 2021 14:24:59 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/</guid>

					<description><![CDATA[Reduced-dose CT depicts greater than 90% of lung nodules in children and young adults with cancer, identifying the presence of nodules with moderate sensitivity and high specificity Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR) Leesburg, VA, July 9, 2021&#8211;According to ARRS&#8217; American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173437</post-id>	</item>
		<item>
		<title>Study sheds light on mechanism of liposome accumulation in tumors</title>
		<link>https://bioengineer.org/study-sheds-light-on-mechanism-of-liposome-accumulation-in-tumors/</link>
					<comments>https://bioengineer.org/study-sheds-light-on-mechanism-of-liposome-accumulation-in-tumors/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jul 2021 16:41:13 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chemistry/Physics/Materials Sciences]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Nanotechnology/Micromachines]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-sheds-light-on-mechanism-of-liposome-accumulation-in-tumors/</guid>

					<description><![CDATA[CU Cancer Center researcher says results could impact how we diagnose, monitor, and treat tumors with liposomes. Credit: CU Cancer Center The new study, titled &#8220;Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label,&#8221; was published on July 1, 2021, in the prestigious journal of the [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-sheds-light-on-mechanism-of-liposome-accumulation-in-tumors/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173377</post-id>	</item>
		<item>
		<title>Chemo upsets gut health in cancer patients</title>
		<link>https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/</link>
					<comments>https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 06 Jul 2021 15:21:47 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Mortality/Longevity]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/</guid>

					<description><![CDATA[New study challenges role of microbiome disruption Credit: SA Health and Medical Research Institute (SAHMRI) New research in BMC Cancer has shown myelosuppressive chemotherapy destabilises gut microbiome in patients with solid organ cancers. The study from SAHMRI and Flinders University assessed the gut health of men and women who underwent conventional chemotherapy on cancers, such [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/chemo-upsets-gut-health-in-cancer-patients/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173047</post-id>	</item>
		<item>
		<title>Reversal speeds creation of important molecule</title>
		<link>https://bioengineer.org/reversal-speeds-creation-of-important-molecule/</link>
					<comments>https://bioengineer.org/reversal-speeds-creation-of-important-molecule/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 29 Jun 2021 17:42:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antitumor Compounds]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chemical Synthesis Efficiency]]></category>
		<category><![CDATA[Chemistry/Physics/Materials Sciences]]></category>
		<category><![CDATA[Halichondrin B]]></category>
		<category><![CDATA[Organic Chemistry Research]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<category><![CDATA[Pharmaceutical/Combinatorial Chemistry]]></category>
		<category><![CDATA[Synthetic Chemistry]]></category>
		<guid isPermaLink="false">https://bioengineer.org/reversal-speeds-creation-of-important-molecule/</guid>

					<description><![CDATA[Rice&#8217;s K.C. Nicolaou lab makes synthesis of halichondrin B more efficient HOUSTON &#8211; (June 29, 2021) &#8211; The story of halichondrin B, an inspirational molecule obtained from a marine creature, goes back to the molecule&#8217;s discovery in an ocean sponge in 1986. Though it has been replicated in the laboratory several times before, new work [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/reversal-speeds-creation-of-important-molecule/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172755</post-id>	</item>
		<item>
		<title>When pandemic hit, some people wanted more sexual activity</title>
		<link>https://bioengineer.org/when-pandemic-hit-some-people-wanted-more-sexual-activity/</link>
					<comments>https://bioengineer.org/when-pandemic-hit-some-people-wanted-more-sexual-activity/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 25 Jun 2021 12:24:05 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Couples]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Normalcy]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Sexual Behavior]]></category>
		<category><![CDATA[Urogenital System]]></category>
		<guid isPermaLink="false">https://bioengineer.org/when-pandemic-hit-some-people-wanted-more-sexual-activity/</guid>

					<description><![CDATA[PITTSBURGH, June 25, 2021 &#8211; It is widely assumed that Americans&#8217; sexual activity took a nosedive during the early chaotic months of the coronavirus pandemic. But a new study from the University of Pittsburgh School of Medicine challenges this popular narrative. In a research letter published in the Journal of Internal Medicine, scientists from Pitt [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/when-pandemic-hit-some-people-wanted-more-sexual-activity/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">172490</post-id>	</item>
		<item>
		<title>Reduced-dose gadobutrol vs standard-dose gadoterate for contrast-enhanced brain MRI</title>
		<link>https://bioengineer.org/reduced-dose-gadobutrol-vs-standard-dose-gadoterate-for-contrast-enhanced-brain-mri/</link>
					<comments>https://bioengineer.org/reduced-dose-gadobutrol-vs-standard-dose-gadoterate-for-contrast-enhanced-brain-mri/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 17 Jun 2021 21:24:19 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Health Care Systems/Services]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Neurochemistry]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/reduced-dose-gadobutrol-vs-standard-dose-gadoterate-for-contrast-enhanced-brain-mri/</guid>

					<description><![CDATA[A 25% reduced gadobutrol dose demonstrated non-inferior efficacy versus 100%-standard dose of gadoterate for contrast-enhanced brain MRI, particularly in patients undergoing multiple contrast-enhanced examinations Leesburg, VA, June 17, 2021&#8211;According to ARRS&#8217; American Journal of Roentgenology (AJR), a reduced dose of gadobutrol is non-inferior to 100%-standard dose of gadoterate for contrast-enhanced brain MRI. &#8220;A 25% reduced [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/reduced-dose-gadobutrol-vs-standard-dose-gadoterate-for-contrast-enhanced-brain-mri/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171990</post-id>	</item>
		<item>
		<title>CSIC scientists propose a new strategy to regulate the cells communication network</title>
		<link>https://bioengineer.org/csic-scientists-propose-a-new-strategy-to-regulate-the-cells-communication-network/</link>
					<comments>https://bioengineer.org/csic-scientists-propose-a-new-strategy-to-regulate-the-cells-communication-network/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 17 Jun 2021 16:39:08 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/csic-scientists-propose-a-new-strategy-to-regulate-the-cells-communication-network/</guid>

					<description><![CDATA[The new tool, designed at the IQAC-CSIC, can help to understand the origin of some diseases and the development of new drugs A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (USA) proposes a new strategy for [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/csic-scientists-propose-a-new-strategy-to-regulate-the-cells-communication-network/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171934</post-id>	</item>
		<item>
		<title>Measuring the elimination of plastic particles from the body in mice</title>
		<link>https://bioengineer.org/measuring-the-elimination-of-plastic-particles-from-the-body-in-mice/</link>
					<comments>https://bioengineer.org/measuring-the-elimination-of-plastic-particles-from-the-body-in-mice/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 16 Jun 2021 15:37:10 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Chemistry/Physics/Materials Sciences]]></category>
		<category><![CDATA[Ecology/Environment]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<category><![CDATA[Pollution/Remediation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/measuring-the-elimination-of-plastic-particles-from-the-body-in-mice/</guid>

					<description><![CDATA[Postdoctoral Researcher Outi Keinänen from the University of Helsinki developed a method to radiolabel plastic particles in order to observe their biodistribution on the basis of radioactivity with the help of positron emission tomography (PET). As a radiochemist, Keinänen has in her previous radiopharmaceutical studies utilised PET imaging combined with computed tomography (CT), which produces [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/measuring-the-elimination-of-plastic-particles-from-the-body-in-mice/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171788</post-id>	</item>
		<item>
		<title>Compounds derived from hops show promise as treatment for common liver disease</title>
		<link>https://bioengineer.org/compounds-derived-from-hops-show-promise-as-treatment-for-common-liver-disease/</link>
					<comments>https://bioengineer.org/compounds-derived-from-hops-show-promise-as-treatment-for-common-liver-disease/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 15 Jun 2021 12:23:24 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Chemistry/Physics/Materials Sciences]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Liver]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Metabolism/Metabolic Diseases]]></category>
		<category><![CDATA[Nutrition/Nutrients]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<guid isPermaLink="false">https://bioengineer.org/compounds-derived-from-hops-show-promise-as-treatment-for-common-liver-disease/</guid>

					<description><![CDATA[CORVALLIS, Ore. &#8211; Research by Oregon State University suggests a pair of compounds originating from hops can help thwart a dangerous buildup of fat in the liver known as hepatic steatosis. The findings, published today in eLife, are important because the condition affects roughly one-fourth of people in the United States and Europe. While heavy [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/compounds-derived-from-hops-show-promise-as-treatment-for-common-liver-disease/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171693</post-id>	</item>
		<item>
		<title>New adaptable nanoparticle platform enables enhanced delivery of gene therapies</title>
		<link>https://bioengineer.org/new-adaptable-nanoparticle-platform-enables-enhanced-delivery-of-gene-therapies/</link>
					<comments>https://bioengineer.org/new-adaptable-nanoparticle-platform-enables-enhanced-delivery-of-gene-therapies/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 09 Jun 2021 16:50:06 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biomedical/Environmental/Chemical Engineering]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Technology Transfer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-adaptable-nanoparticle-platform-enables-enhanced-delivery-of-gene-therapies/</guid>

					<description><![CDATA[Scientists have developed polypeptide-based materials that act as effective vectors for delivering gene therapies. The first-of-its-kind platform enables the vectors to be adapted to suit the specific gene therapy cargo. The work, led by researchers from RCSI University of Medicine and Health Sciences and funded by Science Foundation Ireland, is published in Biomaterials Science. A [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/new-adaptable-nanoparticle-platform-enables-enhanced-delivery-of-gene-therapies/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171357</post-id>	</item>
		<item>
		<title>Cell Reports publishes data supporting the importance of ion channel, Kv7.2/7.3 as a target in ALS</title>
		<link>https://bioengineer.org/cell-reports-publishes-data-supporting-the-importance-of-ion-channel-kv7-2-7-3-as-a-target-in-als/</link>
					<comments>https://bioengineer.org/cell-reports-publishes-data-supporting-the-importance-of-ion-channel-kv7-2-7-3-as-a-target-in-als/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 08 Jun 2021 20:23:10 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Neurochemistry]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cell-reports-publishes-data-supporting-the-importance-of-ion-channel-kv7-2-7-3-as-a-target-in-als/</guid>

					<description><![CDATA[Data supports QurAlis&#8217; approach to treat hyperexcitability induced neurodegeneration in ALS patients; QurAlis gears up for clinical development of therapeutic candidate, QRL-101 CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;QurAlis Corporation, a biotech company developing breakthrough precision medicines for ALS and other genetically validated neurodegenerative diseases, today announced the publication of an article in Cell Reports titled Human Amyotrophic Lateral [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/cell-reports-publishes-data-supporting-the-importance-of-ion-channel-kv7-2-7-3-as-a-target-in-als/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171266</post-id>	</item>
		<item>
		<title>New drug-formulation method may lead to smaller pills</title>
		<link>https://bioengineer.org/new-drug-formulation-method-may-lead-to-smaller-pills/</link>
					<comments>https://bioengineer.org/new-drug-formulation-method-may-lead-to-smaller-pills/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 07 Jun 2021 20:21:15 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Nanotechnology/Micromachines]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-drug-formulation-method-may-lead-to-smaller-pills/</guid>

					<description><![CDATA[Chemical engineers have found a way to load more drug into a tablet, which could then be made smaller and easier to swallow CAMBRIDGE, MA &#8212; About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/new-drug-formulation-method-may-lead-to-smaller-pills/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171135</post-id>	</item>
		<item>
		<title>Study helps to deeper understanding of brain dysfunctions in patients with schizophrenia</title>
		<link>https://bioengineer.org/study-helps-to-deeper-understanding-of-brain-dysfunctions-in-patients-with-schizophrenia/</link>
					<comments>https://bioengineer.org/study-helps-to-deeper-understanding-of-brain-dysfunctions-in-patients-with-schizophrenia/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 07 Jun 2021 19:24:05 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Molecular Biology]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical/Combinatorial Chemistry]]></category>
		<category><![CDATA[Physiology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-helps-to-deeper-understanding-of-brain-dysfunctions-in-patients-with-schizophrenia/</guid>

					<description><![CDATA[Researchers used protein mapping to show how abnormal levels of the neurotransmitter glutamate impair the functioning of neurons and oligodendrocytes. The findings could serve as a basis for more effective treatment A study conducted by a group of Brazilian researchers contributes to a deeper understanding of the molecular basis for schizophrenia, and potentially to the [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-helps-to-deeper-understanding-of-brain-dysfunctions-in-patients-with-schizophrenia/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171123</post-id>	</item>
		<item>
		<title>Unexpected discovery opens a new way to regulate blood pressure</title>
		<link>https://bioengineer.org/unexpected-discovery-opens-a-new-way-to-regulate-blood-pressure/</link>
					<comments>https://bioengineer.org/unexpected-discovery-opens-a-new-way-to-regulate-blood-pressure/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 07 Jun 2021 18:27:14 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[neurobiology]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Stroke]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unexpected-discovery-opens-a-new-way-to-regulate-blood-pressure/</guid>

					<description><![CDATA[International research team uncovers underappreciated metal&#8217;s role in lowering blood pressure High blood pressure, or hypertension, is the leading modifiable risk factor for cardiovascular diseases and premature death worldwide. And key to treating patients with conditions ranging from chest pain to stroke is understanding the intricacies of how the cells around arteries and other blood [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/unexpected-discovery-opens-a-new-way-to-regulate-blood-pressure/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">171101</post-id>	</item>
	</channel>
</rss>
